OVID
Ovid Therapeutics·NASDAQ
--
--(--)
--
--(--)
4.35 / 10
Netural
Fund flow metrics score 7.55/10, revealing robust fund flow characteristics. Beneficial Small trends are challenged by problematic overall, block, Medium, Large, and Extra-large signals, indicating positive capital movement. Professional analyst opinion suggests overwhelmingly bullish analyst consensus, showing strong conviction. Distribution pattern: Strong Buy(100.0%) based on 2 research evaluations, supported by 1.16 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-11
InstitutionRoth Capital
Times predicted1
Historical Win Rate0.0%
What is the market sentiment for OVID?
- OVID holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.35/10 (Netural).
